Log In
Print
BCIQ
Print
Print this Print this
 

NGR-hTNF (formerly Arenegyr)

  Manage Alerts
Collapse Summary General Information
Company MolMed S.p.A.
DescriptionRecombinant fusion protein that selectively binds to alanyl membrane aminopeptidase (ANPEP; APN; CD13)
Molecular Target Alanyl membrane aminopeptidase (ANPEP) (APN) (CD13)
Mechanism of ActionBinds CD13
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today